Affiliation:
1. Department of Otolaryngology‐Head and Neck Surgery Soroka University Medical Center, Faculty of Health Sciences, Ben‐Gurion University of the Negev Beer‐Sheva Israel
2. The Pediatric Infectious Disease Unit Soroka University Medical Center, The Faculty of Health Sciences, Ben‐Gurion University of the Negev Beer‐Sheva Israel
Abstract
AbstractObjectivesPeritonsillar abscess (PTA) is the most common soft‐tissue infection of the head and neck. This potential complication of tonsillitis has demonstrated unique microbial trends during the COVID‐19 pandemic. This era has resulted in a major shift in the hygiene and social habits of the general population, which has resulted in changes in the presentation, management and microbiology of several infectious diseases. To date, the impact of COVID 19 on PTA microbiology and clinical presentation in the paediatric population has yet to be investigated.DesignRetrospective chart review comparing all cases of paediatric (age 0–18) PTA in an academic tertiary centre during the COVID‐19 pandemic (03/2020–02/2022) and compared them to two control groups: pre‐COVID (03/2018–02/2020) and post‐COVID (03/2022–03/2023). All patients were treated with either needle aspiration, incision and drainage or both means in addition to intravenous antibiotics.SettingA large Ear Nose and Throat department in a tertiary referral center.ParticipantsConsecutive children aged 18 years or under, admitted with a diagnosis of Peritonsillar abscess.Main Outcome MeasuresWe analyzed the clinical and microbiologcal features of all cases of pediatric peritonsillar abscess during the COVID‐19 era (03/2020‐02/2022) and compared them to a pre and post control cases.ResultsA total of 96 PTA cases were included (35 pre‐COVID, 35 COVID and 26 post‐COVID). The means of procedural treatment shifted in favour of incision and drainage versus needle aspiration during the COVID era. The length of hospitalisation increased during the COVID era (3.6 days vs. 2.1 and 3.1 pre and post‐COVID respectively, p < .001). No other notable differences in the clinical and demographic features were found between the three eras. The COVID‐19 era saw an increase in Fusobacterium (37.1% vs. 8.6% and 24% pre and post‐COVID, respectively; p = .008) and Streptococcus Anginosus (31.4% vs. 5.7% and 7.7% pre and post‐COVID, respectively; p = .007) species isolation.ConclusionsThe COVID‐19 pandemic did not seem to impact the clinical presentation of paediatric PTA yet resulted in a change in microbiological pathogens. The choice of I&D as a means to shorten hospital stay during the pandemic may have led to an actual increase in hospital stay, suggesting that NA may be the preferred management approach.